|
|
| MRD / Regn No. |
: 20210000453 |
Date |
: 15/07/2026 |
| Patient Name |
: Shylaja Kesavan |
Age & Gender |
: 36 Yrs. / Female |
| Contact No. |
: 8838328209 |
UHID |
: |
| Ht / Wt / BMI |
: 170 / 90.5 / 31.31 |
BP S / BP D |
: 117 / 87 |
| Allergies |
: NKA |
Referred By |
: G Vishnuvandana |
| |
|
| Problem
List |
: |
TYPE 2 DM (13/May/2021) | |
|
Subjective |
: |
LOST TO FOLLOW UP
|
|
Objective |
: |
NONE |
|
Analysis |
: |
PREDIABETES,OBESITY,VITAMIN D DEFICEINCY |
|
Plan |
: |
LIFESTYLE,START MOUNJARO |
|
| Salient Investigations |
: |
VITAMIN D (25 OH): 8.1 ng/mL | HEMOGLOBIN: 11.2 g/dL | IRON: 59 mcg/dL | MCV - MEAN CORPUSCULAR VOLUME: 85.3 fL | PLATELETS: 251 thou cells/ ul | VITAMIN B12: >2000 pg/mL | WBC WHITE BLOOD CELLS: 818 K/uL | FASTING PLASMA GLUCOSE (FPG): 105 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 5.6 % | FREE T3: 2.2 ng/dL | FREE T4 : 0.9 ng/dL | TSH : 2.7 mIU/L | HDL HIGH DENSITY LIPOPROTEIN: 47 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 134 mg/dL | TGL TRIGLYCERIDE: 87 mg/dL | TOTAL CHOLESTEROL: 196 mg/dl | ALBUMIN (SERUM): 3.9 g/dL | ALKALINE PHOSPHOTASE: 77 IU/L | DIRECT BILIRUBIN: 0.1 mg/dl | SGOT (AST): 9 U/L | SGPT (ALT): 7 IU/L | TOTAL BILIRUBIN: 0.3 mg/dL | CREATININE: 0.9 mg/dL | UREA: 19 mg/dL | URIC ACID: 4.3 | BICARBONATE: 25 meq/L | CHLORIDE: 105 meq/L | POTASSIUM: 3.7 meQ/L | SODIUM: 140 meq/L | FUNDUS GLAUCOMA: NDR | FUNDUS MACULAR DEGENERATION: NAD | FUNDUS PHOTOGRAPH: NAD | OCULAR PRESSURE LEFT: 0.4 mmHg | OCULAR PRESSURE R: 0.4 mm HG | FIB4: 0.49 | FIB4: 0.49 | EGFR EGLOMERULAR FILTRATION RATE: 75.79 mL/min/1.73m2 | EGFR EGLOMERULAR FILTRATION RATE: 75.79 mL/min/1.73m2 | FUNDUS GLAUCOMA: NDR | FUNDUS MACULAR DEGENERATION: NAD | FUNDUS PHOTOGRAPH: NAD | OCULAR PRESSURE LEFT: 0.4 mmHg | OCULAR PRESSURE R: 0.4 mm HG |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
CAPSULE CHOLECALCIFEROL 2000 IU
D RISE
Medicine For VITAMIN D |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
|
|
2 |
GEL CHOLECALCIFEROL 60000 IU
ARACHITOL NANO
Medicine For VITAMIN D |
PO |
ONCE A WEEK |
DRINK LIQUID AS IS
|
2 WEEKS |
|
|
3 |
INJECTION TIRZEPATIDE 2.5 MG
YURPEAK
Medicine For DIABETES OBESITY WEIGHT LOSS |
SQ |
ONCE A WEEK |
AS DIRECTED NO RELATION TO FOOD
|
|
| MAY CAUSE NAUSEA VOMITING OR DIARREHA | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 16/Jul/2026 |
| Tests Suggested For Next Visit |
: NONE |
| |
|
| |
|
Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu /
48748 HPRID: 71-0638-2075-7542
This is a Computer generated Prescription |
Powered By:  |